Brevan Howard Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,636
| Closed | -$40.6K | – | 1213 |
|
|
2024
Q4 | $40.6K | Buy |
+24,636
| New | +$40.6K | ﹤0.01% | 959 |
|
|
2024
Q3 | – | Sell |
-24,223
| Closed | -$79.5K | – | 1179 |
|
|
2024
Q2 | $79.5K | Buy |
+24,223
| New | +$79.5K | ﹤0.01% | 934 |
|
|
2024
Q1 | – | Sell |
-38,230
| Closed | -$143K | – | 1059 |
|
|
2023
Q4 | $143K | Buy |
38,230
+20,893
| +121% | +$78.1K | ﹤0.01% | 874 |
|
|
2023
Q3 | $36.8K | Buy |
+17,337
| New | +$36.8K | ﹤0.01% | 314 |
|